bs-83416C [Life Science]
Abemaciclib
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Formulation Off-white solid

Storage: -20°C

Product Information:

Abemaciclib (1231930-82-7) is a potent and selective CDK4/6 inhibitor (IC50 = 2 nM and 10 nM respectively).1 It caused G1 cell cycle arrest in colo-205 colorectal cells, MDA-MB-361 breast cancer cells, and MV4-11 AML cells. Abemaciclib was also active in several human tumor xenograft models. It displayed efficacy in patients with various solid tumors including breast cancer, non-small cell lung cancer, glioblastoma, melanoma, colorectal cancer, and hormone receptor-positive breast cancer.2 Abemaciclib induced a T cell inflamed tumor microenvironment and enhanced the efficacy of PD-L1 checkpoint blockade in MCF-7 breast cancer cells.3 FDA approved for the treatment of advanced breast cancers.

Description:

CAS Number: 1231930-82-7<br></br>Chemical Name: CDK 4/6 inhibitor<br></br>Molecular Weight: 602.70<br></br>Formula: C27H32F2N8·CH3SO3H <br></br>Solubility: DMSO > 25 mg/ml Water > 25 mg/ml<br></br>Physical Properties: Off-white solid<br></br>Purity: >98% by HPLC NMR (Conforms)

Size: 50mg,10mg

Applications: Life Science()

For research use only. Not intended for diagnostic or therapeutic use.